Skip to main content
Clinical Trials/RBR-22pqs9
RBR-22pqs9
Recruiting
Phase 1

Bioactive compounds supplementation effects on the gene expression of inflammatory markers and macrophage infiltration in obese women

Flávia Campos Corgosinho0 sitesDecember 17, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Obesity
Sponsor
Flávia Campos Corgosinho
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 17, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention
Sex
Female

Investigators

Sponsor
Flávia Campos Corgosinho

Eligibility Criteria

Inclusion Criteria

  • Obese women with BMI above 40kg / m² between 20 and 59 years of age.

Exclusion Criteria

  • Presence of acute inflammatory diseases; infectious diseases; neoplastic diseases; genetic syndromes; present age under 20 years; chronic consumption of vitamin supplements; alcohol (\> 30g / day) (SBD, 2017\); illicit drugs; do not live in the metropolitan region of goiania; swallowing problems and presenting any kind of intolerance or allergies to food supplement sources.

Outcomes

Primary Outcomes

Not specified

Similar Trials